by Insulin-Like Growth Factor-I Promotion of Macrophage Differentiation Phosphatidylinositol 3'-Kinase and Activation of Protein Kinase C-{zeta} and

[1]  J. Verhoef,et al.  Quantitation of surface CD14 on human monocytes and neutrophils , 1997, Journal of leukocyte biology.

[2]  G. Evan,et al.  Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB , 1997, Nature.

[3]  David R. Kaplan,et al.  Regulation of Neuronal Survival by the Serine-Threonine Protein Kinase Akt , 1997, Science.

[4]  D. Leroith,et al.  Insulin-like Growth Factor 1 Inhibits Apoptosis Using the Phosphatidylinositol 3′-Kinase and Mitogen-activated Protein Kinase Pathways* , 1997, The Journal of Biological Chemistry.

[5]  R. Abraham,et al.  Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3‐kinase inhibitors, wortmannin and LY294002. , 1996, The EMBO journal.

[6]  M. Palacín,et al.  Phosphatidylinositol 3-Kinase Inhibitors Block Differentiation of Skeletal Muscle Cells* , 1996, The Journal of Biological Chemistry.

[7]  M. Owen,et al.  The MAP Kinase Pathway Controls Differentiation from Double-Negative to Double-Positive Thymocyte , 1996, Cell.

[8]  G. Cooper,et al.  Activation of the CPP32 Apoptotic Protease by Distinct Signaling Pathways with Differential Sensitivity to Bcl-xL* , 1996, The Journal of Biological Chemistry.

[9]  D. Jelinek,et al.  Phosphatidylinositol 3-kinase activation in normal human B lymphocytes. , 1996, Journal of immunology.

[10]  E. Kremmer,et al.  Protein kinase C-zeta reverts v-raf transformation of NIH-3T3 cells. , 1996, Genes & development.

[11]  R. Abraham.  Phosphatidylinositol 3-kinase related kinases. , 1996, Current opinion in immunology.

[12]  Xiaozhong Wang,et al.  Stress-Induced Phosphorylation and Activation of the Transcription Factor CHOP (GADD153) by p38 MAP Kinase , 1996, Science.

[13]  A. Ullrich,et al.  ERK6, a mitogen-activated protein kinase involved in C2C12 myoblast differentiation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[14]  S. Arkins,et al.  Requirement for phosphatidylinositol 3'-kinase to protect hemopoietic progenitors against apoptosis depends upon the extracellular survival factor. , 1996, Journal of immunology.

[15]  Y. Giudicelli,et al.  Zeta PKC in rat preadipocytes: modulation by insulin and serum mitogenic factors and possible role in adipogenesis. , 1995, Biochemical and biophysical research communications.

[16]  Y. Nonomura,et al.  Biochemical and pharmacological studies with KT7692 and LY294002 on the role of phosphatidylinositol 3-kinase in Fc epsilon RI-mediated signal transduction. , 1995, The Biochemical journal.

[17]  F. Lund-Johansen,et al.  Expression of leukocyte differentiation antigens during the differentiation of HL‐60 cells induced by 1,25‐dihydroxyvitamin D3: comparison with the maturation of normal monocytic and granulocytic bone marrow cells , 1995, Journal of leukocyte biology.

[18]  S. Rosenthal,et al.  Opposing early and late effects of insulin-like growth factor I on differentiation and the cell cycle regulatory retinoblastoma protein in skeletal myoblasts. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[19]  H. Schneider,et al.  Selective CD28pYMNM mutations implicate phosphatidylinositol 3-kinase in CD86-CD28-mediated costimulation. , 1995, Immunity.

[20]  M. Connelly,et al.  DNA-dependent protein kinase catalytic subunit: A relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene product , 1995, Cell.

[21]  B. Burgering,et al.  Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction , 1995, Nature.

[22]  J. Blalock,et al.  Associations between the neuroendocrine and immune systems , 1995, Journal of leukocyte biology.

[23]  G. Evan,et al.  Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. , 1995, The Journal of clinical investigation.

[24]  G. Cooper,et al.  Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. , 1995, Science.

[25]  S. Arkins,et al.  The colony-stimulating factors induce expression of insulin-like growth factor-I messenger ribonucleic acid during hematopoiesis. , 1995, Endocrinology.

[26]  E. Prossnitz,et al.  Investigation of neutrophil signal transduction using a specific inhibitor of phosphatidylinositol 3-kinase. , 1995, Journal of immunology.

[27]  L. Sanz,et al.  Evidence for the in vitro and in vivo interaction of Ras with protein kinase C zeta. , 1994, The Journal of biological chemistry.

[28]  R. Baserga.  Oncogenes and the strategy of growth factors , 1994, Cell.

[29]  L. Freedman,et al.  Transcriptional synergism between the vitamin D3 receptor and other nonreceptor transcription factors. , 1994, Molecular endocrinology.

[30]  J. Blalock,et al.  The syntax of immune-neuroendocrine communication. , 1994, Immunology today.

[31]  J. Chen,et al.  Overexpression of protein kinase C-zeta stimulates leukemic cell differentiation. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[32]  J. Florini,et al.  IGF‐II is more active than IGF‐I in stimulating L6A1 myogenesis: Greater mitogenic actions of IGF‐I delay differentiation , 1994, Journal of cellular physiology.

[33]  J. Zwiller,et al.  Insulin-like growth factor-I stimulates c-fos and c-jun transcription in PC12 cells , 1994, Molecular and Cellular Endocrinology.

[34]  D. Riches,et al.  Functional switching of macrophage responses to tumor necrosis factor-alpha (TNF alpha) by interferons. Implications for the pleiotropic activities of TNF alpha. , 1994, The Journal of clinical investigation.

[35]  K Y Hui,et al.  A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). , 1994, The Journal of biological chemistry.

[36]  T. Okada,et al.  Blockage of chemotactic peptide-induced stimulation of neutrophils by wortmannin as a result of selective inhibition of phosphatidylinositol 3-kinase. , 1994, The Journal of biological chemistry.

[37]  J. Ketelslegers,et al.  Nutritional regulation of the insulin-like growth factors. , 1994, Endocrine reviews.

[38]  L. Gibson,et al.  Insulin-like growth factor-1 potentiates expansion of interleukin-7-dependent pro-B cells. , 1993, Blood.

[39]  A. Skottner,et al.  Comparative studies of the granulopoietic enhancing effects of biosynthetic human insulin‐like growth factors I and II , 1993, Journal of cellular physiology.

[40]  T. M. Dexter,et al.  Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors , 1993, Cell.

[41]  F. Lund-Johansen,et al.  Differential surface expression of cell adhesion molecules during granulocyte maturation , 1993, Journal of leukocyte biology.

[42]  Y. Mizuguchi,et al.  Intracellular multiplication of Legionella pneumophila in HL‐60 cells differentiated by 1,25‐dihydroxyvitamin D3 and the effect of interferon y , 1993, Journal of leukocyte biology.

[43]  F. Gros,et al.  Muscle differentiation: insulin-like growth factors as positive modulators of myogenic regulatory genes? , 1993, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

[44]  H. Hug,et al.  Protein kinase C isoenzymes: divergence in signal transduction? , 1993, The Biochemical journal.

[45]  N. Ruderman,et al.  Insulin-stimulated phosphatidylinositol 3-kinase. Association with a 185-kDa tyrosine-phosphorylated protein (IRS-1) and localization in a low density membrane vesicle. , 1993, The Journal of biological chemistry.

[46]  J. Exton,et al.  Activation of the zeta isozyme of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate. , 1993, The Journal of biological chemistry.

[47]  C. Kahn,et al.  Insulin stimulation of phosphatidylinositol 3-kinase activity and association with insulin receptor substrate 1 in liver and muscle of the intact rat. , 1992, The Journal of biological chemistry.

[48]  Y. Nishizuka.  Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. , 1992, Science.

[49]  M. Collins,et al.  Insulin-like growth factor-I inhibits apoptosis in IL-3-dependent hemopoietic cells. , 1992, Journal of immunology.

[50]  M. Schalling,et al.  Insulin-like growth factor I shifts from promoting cell division to potentiating maturation during neuronal differentiation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[51]  J R Florini,et al.  "Spontaneous" differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II. , 1991, The Journal of biological chemistry.

[52]  C. Conover,et al.  Insulin-like growth factor (IGF)-binding protein-3 blocks IGF-I-induced receptor down-regulation and cell desensitization in cultured bovine fibroblasts. , 1991, Endocrinology.

[53]  R. Gaynor,et al.  Expression of c-jun during macrophage differentiation of HL-60 cells. , 1991, Blood.

[54]  J. Florini,et al.  Insulin-like growth factor-I stimulates terminal myogenic differentiation by induction of myogenin gene expression. , 1991, Molecular endocrinology.

[55]  A. Allison,et al.  Insulin-like growth factor-1 increases the mitogenic response of human peripheral blood lymphocytes to phytohemagglutinin. , 1989, Immunology letters.

[56]  P. Smith,et al.  Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes. , 1988, The Journal of biological chemistry.

[57]  Z. Hochberg,et al.  Enhancement of human granulopoiesis in vitro by biosynthetic insulin-like growth factor I/somatomedin C and human growth hormone. , 1988, The Journal of clinical investigation.

[58]  S. Collins,et al.  The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. , 1987, Blood.

[59]  T. Hamilton,et al.  Molecular Transductional Mechanisms by which IFNγ and Other Signals Regulate Macrophage Development , 1987, Immunological reviews.

[60]  P. Cuatrecasas,et al.  Monoclonal antibodies to receptors for insulin and somatomedin-C. , 1983, The Journal of biological chemistry.

[61]  M. W. Wooten,et al.  Nerve growth factor-induced differentiation of PC12 cells employs the PMA-insensitive protein kinase C-ζ isoform , 2007, Journal of Molecular Neuroscience.

[62]  Yong Ming Li,et al.  Regulation of Myeloid Growth and Differentiation by the Insulin-Like Growth Factor I Receptor1. , 1997, Endocrinology.

[63]  E. Hooghe-Peters,et al.  Prolactin, growth hormone, and insulin-like growth factor-I in the immune system. , 1996, Advances in immunology.

[64]  Z. Darżynkiewicz,et al.  Assays of cell viability: discrimination of cells dying by apoptosis. , 1994, Methods in cell biology.

[65]  K. Dorshkind,et al.  Insulin-like growth factor-I regulates pro-B cell differentiation. , 1992, Blood.

[66]  M. Rechler,et al.  Insulin-like growth factor receptors. , 1985, Journal of cell science. Supplement.